Inhibitors of α4 mediated cell adhesion
AssigneeTanabe Seiyaku Co., Ltd.
InventorsIla Sircar, Kristjan S. Gudmundsson, Richard Martin
Life of this patent
Estimating the term…
Loading patent…
AssigneeTanabe Seiyaku Co., Ltd.
InventorsIla Sircar, Kristjan S. Gudmundsson, Richard Martin
Estimating the term…
The present invention relates to a pharmaceutical composition comprising as an active ingredient a compound of formula (I), wherein Ring A is an aromatic or a heterocyclic ring; Q is a bond, carbonyl, lower alkylene, lower alkenylene, —O— -(lower alkylene)-, etc.; n is 0, 1 or 2; Z is oxygen or sulfur; W is oxygen, sulfur, —CH═CH—, —NH— or —N═CH—; R1, R2 and R3 are the same or different and are hydrogen, halogen, hydroxyl, a substituted or unsubstituted lower alkyl gorup, a substituted or unsubstituted lower alkoxy group, a substituted or unsubstituted amino group, etc.; R4 is tetrazolyl, carboxyl group, amide or ester; R5 is hydrogen, nitro, amino, hydroxyl, lower alkanoyl, lower alkyl, etc.; R6 is selected from (a) a substituted or unsubstituted phenyl group, (b) a substituted or unsubstituted pyridyl group, (c) a substituted or unsubstituted thienyl group, (d) a substituted or unsubstituted benzofuranyl group, etc.; or a pharmaceutically acceptable salt thereof.
A compound of formula [III]:
4-(2,6-dimethoxyphenyl)-L-phenylalanine, a lower alkyl ester, or a salt thereof.
4-(2,6-dimethoxyphenyl)-L-phenylalanine methyl ester.
Dependencies are inferred from the claim text.